Evidence map›Paper›PMID 40528583›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Prioritize a multidisciplinary approach to the diagnosis and management of portal hypertension].

Z G Zhang, X P Chen

Abstract readEnglish Abstract
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Z G ZhangHepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
X P ChenHepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Funding

National Natural Science Foundation of China 82172976Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0525002Outstanding Youth Foundation of Hubei Province 2024AFA076
6 · The paper itself

Abstract

Portal hypertension primarily arises from chronic liver disease, which seriously affects people's lives and health, and its treatment has always been considered complex and diverse. With the innovation of ideas and technologies, its treatment model has transitioned from unidisciplinary to multidisciplinary collaborative diagnosis and treatment. The treatment of portal hypertension tends to be more individualized, standardized, and minimally invasive under the multidisciplinary diagnosis and treatment model. Furthermore, the greatest extent of therapeutic effect for portal hypertension can be optimized by multidisciplinary collaboration and selection of individualized diagnosis and treatment methods for different populations. Therefore, it is imperative to diagnose and treat portal hypertension propensity in a multidisciplinary collaboration.

Indexed as

Hypertension, PortalPatient Care TeamHumans

Identifiers

PMID40528583
PMCPMC12861864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.